SCHEMBL4583833

SCHEMBL4583833

CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC1OC1(C)CCC1OC1(C)C

nearest known ligand 0.89

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LSS P48449 11/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4583832 1.00 LSS (0.65) LSS
SCHEMBL188732 0.89 LSS (0.78) LSS
SCHEMBL1009221 0.89 LSS (0.78) LSS
SCHEMBL1142772 0.89 LSS (0.78) LSS
SCHEMBL1401906 0.89 LSS (0.78) LSS
SCHEMBL29711785 0.84 LSS (0.83) LSS
SCHEMBL29711771 0.84 LSS (0.83) LSS
SCHEMBL2833064 0.81 LSS (0.66) LSS
SCHEMBL19105136 0.79 LSS (0.46) LSS
SCHEMBL4053634 0.78 KMT2A (0.49) LSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111108213-B Method for preparing high intensity sweetener 弗门尼舍公司 2024-12-13 CN claimed
CN-111108213-A Process for preparing high intensity sweeteners 弗门尼舍公司 2020-05-05 CN claimed
CN-119709929-A Method for preparing high intensity sweetener 弗门尼舍公司 2025-03-28 CN disclosed
CN-113302298-B Biosynthesis of mogrosides 银杏生物制品公司 2025-02-25 CN disclosed
CN-111108213-B Method for preparing high intensity sweetener 弗门尼舍公司 2024-12-13 CN disclosed
CN-117460825-A Biosynthesis of isoprenoids and their precursors 银杏生物制品公司 2024-01-26 CN disclosed
CN-115335514-A Biosynthesis of mogrosides 银杏生物制品公司 2022-11-11 CN disclosed
CN-113316394-A Process for preparing high intensity sweeteners 弗门尼舍公司 2021-08-27 CN disclosed
CN-113286523-A Process for preparing high intensity sweeteners 弗门尼舍公司 2021-08-20 CN disclosed
CN-111108213-A Process for preparing high intensity sweeteners 弗门尼舍公司 2020-05-05 CN disclosed
US-7439027-B2 Method for modulating process mediated by farnesoid activated receptors THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 2008-10-21 US disclosed
WO-1998032444-A1 USE OF FXR, PPARα AND LXRα ACTIVATORS TO RESTORE BARRIER FUNCTION, PROMOTE EPIDERMAL DIFFERENTIATION AND INHIBIT PROLIFERATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1998-07-30 WO disclosed
EP-0808374-A1 METHOD FOR MODULATING PROCESSES MEDIATED BY FARNESOID ACTIVATED RECEPTORS THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 1997-11-26 EP disclosed
CN-1160403-A Substd. heterobicyclic alkyl amines and their use as squalene oxide cyclase inhibitors TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1997-09-24 CN disclosed
WO-1996021742-A1 METHOD FOR MODULATING PROCESSES MEDIATED BY FARNESOID ACTIVATED RECEPTORS THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 1996-07-18 WO disclosed
EP-0676960-A4 1995-11-15 EP disclosed
EP-0676960-A1 CYCLOALKYL AMINE BIS-ARYL SQUALENE SYNTHASE INHIBITORS RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1995-10-18 EP disclosed
WO-1995000146-A1 AMINO BI- AND TRI-CARBOCYCLIC ALKANE BIS-ARYL SQUALENE SYNTHASE INHIBITORS RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1995-01-05 WO disclosed
WO-1994027601-A1 ALIPHATIC AMINO BIS-ARYL SQUALENE SYNTHASE INHIBITORS RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1994-12-08 WO disclosed
WO-1994014435-A1 CYCLOALKYL AMINE BIS-ARYL SQUALENE SYNTHASE INHIBITORS RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1994-07-07 WO disclosed